{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:09:46Z","timestamp":1744344586607,"version":"3.40.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["KSN1621131","KSN1621131","KSN2213010","KSN2213010"],"award-info":[{"award-number":["KSN1621131","KSN1621131","KSN2213010","KSN2213010"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96884-w","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:07:06Z","timestamp":1744286826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptome signatures of human neural stem cells derived from LRRK2 gene therapeutic cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Doyeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seo-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Ku","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"96884_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh, S. & Arachchige, A. S. P. M. Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature. AIMS Neurosci. 10, 200 (2023).","journal-title":"AIMS Neurosci."},{"key":"96884_CR2","doi-asserted-by":"publisher","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","volume":"290","author":"JP Daher","year":"2015","unstructured":"Daher, J. P. et al. Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates \u03b1-synuclein gene-induced neurodegeneration. J. Biol. Chem. 290, 19433\u201319444 (2015).","journal-title":"J. Biol. Chem."},{"key":"96884_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molmed.2012.12.005","volume":"19","author":"G Mercado","year":"2013","unstructured":"Mercado, G., Vald\u00e9s, P. & Hetz, C. An ERcentric view of Parkinson\u2019s disease. Trends Mol. Med. 19, 165\u2013175 (2013).","journal-title":"Trends Mol. Med."},{"key":"96884_CR4","doi-asserted-by":"publisher","first-page":"e22354","DOI":"10.1371\/journal.pone.0022354","volume":"6","author":"Y Yuan","year":"2011","unstructured":"Yuan, Y. et al. Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PLoS ONE 6, e22354 (2011).","journal-title":"PLoS ONE"},{"key":"96884_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0716-4","volume":"7","author":"JH Lee","year":"2019","unstructured":"Lee, J. H. et al. Parkinson\u2019s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes. Acta Neuropathol. Commun. 7, 1\u201319 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"96884_CR6","doi-asserted-by":"publisher","unstructured":"Steger, M. et al. Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases. Elife 5, https:\/\/doi.org\/10.7554\/eLife.12813 (2016).","DOI":"10.7554\/eLife.12813"},{"key":"96884_CR7","doi-asserted-by":"publisher","first-page":"165632","DOI":"10.1016\/j.bbadis.2019.165632","volume":"1866","author":"EJ Bae","year":"2020","unstructured":"Bae, E. J. & Lee, S. J. The LRRK2-RAB axis in regulation of vesicle trafficking and alpha-synuclein propagation. Biochim Biophys Acta Mol Basis Dis 1866, 165632. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165632 (2020).","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"96884_CR8","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.15252\/embj.201487807","volume":"33","author":"HJ Cho","year":"2014","unstructured":"Cho, H. J. et al. Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. EMBO J 33, 2314\u20132331. https:\/\/doi.org\/10.15252\/embj.201487807 (2014).","journal-title":"EMBO J"},{"key":"96884_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/hmg\/ddr481","volume":"21","author":"P G\u00f3mez-Suaga","year":"2012","unstructured":"G\u00f3mez-Suaga, P. et al. Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP. Hum. Mol. Genet. 21, 511\u2013525 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"96884_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","volume":"111","author":"J Schapansky","year":"2018","unstructured":"Schapansky, J. et al. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble alpha-synuclein in neurons. Neurobiol Dis 111, 26\u201335. https:\/\/doi.org\/10.1016\/j.nbd.2017.12.005 (2018).","journal-title":"Neurobiol Dis"},{"key":"96884_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1242\/jcs.164152","volume":"128","author":"LN Hockey","year":"2015","unstructured":"Hockey, L. N. et al. Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition. J Cell Sci 128, 232\u2013238. https:\/\/doi.org\/10.1242\/jcs.164152 (2015).","journal-title":"J Cell Sci"},{"key":"96884_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: A case-control study. Lancet Neurol 7, 583\u2013590. https:\/\/doi.org\/10.1016\/S1474-4422(08)70117-0 (2008).","journal-title":"Lancet Neurol"},{"key":"96884_CR13","doi-asserted-by":"publisher","first-page":"e26609","DOI":"10.1371\/journal.pone.0026609","volume":"6","author":"N Badiola","year":"2011","unstructured":"Badiola, N. et al. Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS ONE 6, e26609. https:\/\/doi.org\/10.1371\/journal.pone.0026609 (2011).","journal-title":"PLoS ONE"},{"key":"96884_CR14","doi-asserted-by":"publisher","unstructured":"Hur, E. M. & Lee, B. D. LRRK2 at the crossroad of aging and Parkinson\u2019s disease. Genes (Basel) 12, https:\/\/doi.org\/10.3390\/genes12040505 (2021).","DOI":"10.3390\/genes12040505"},{"key":"96884_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13024-015-0022-y","volume":"10","author":"S Saha","year":"2015","unstructured":"Saha, S. et al. Mutations in LRRK2 potentiate age-related impairment of autophagic flux. Mol Neurodegener 10, 26. https:\/\/doi.org\/10.1186\/s13024-015-0022-y (2015).","journal-title":"Mol Neurodegener"},{"key":"96884_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11557","volume":"491","author":"GH Liu","year":"2012","unstructured":"Liu, G. H. et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 491, 603\u2013607. https:\/\/doi.org\/10.1038\/nature11557 (2012).","journal-title":"Nature"},{"key":"96884_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601\u2013607 (2004).","journal-title":"Neuron"},{"key":"96884_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","volume":"12","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt, P. et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354\u2013367. https:\/\/doi.org\/10.1016\/j.stem.2013.01.008 (2013).","journal-title":"Cell Stem Cell"},{"key":"96884_CR19","doi-asserted-by":"publisher","first-page":"101649","DOI":"10.1016\/j.scr.2019.101649","volume":"41","author":"S-Y Lee","year":"2019","unstructured":"Lee, S.-Y. & Chung, S.-K. Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson\u2019s disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination. Stem Cell Res. 41, 101649 (2019).","journal-title":"Stem Cell Res."},{"key":"96884_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mds.24962","volume":"27","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos, M., Levy, O. A. & Alcalay, R. N. The neuropathology of genetic Parkinson\u2019s disease. Mov. Disord. 27, 831\u2013842 (2012).","journal-title":"Mov. Disord."},{"key":"96884_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X., Sengupta, M., Trojanowski, J. Q. & Lee, V. M. Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol. Commun. 7, 1\u201316 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"96884_CR22","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.neurobiolaging.2009.11.019","volume":"32","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y. et al. LRRK2 variant associated with Alzheimer\u2019s disease. Neurobiol. Aging 32, 1990\u20131993 (2011).","journal-title":"Neurobiol. Aging"},{"issue":"2889","key":"96884_CR23","first-page":"e2885","volume":"34","author":"H Ling","year":"2013","unstructured":"Ling, H. et al. TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p. Q124E MAPT. Neurobiol. Aging 34(2889), e2885-2889 (2013).","journal-title":"Neurobiol. Aging"},{"key":"96884_CR24","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.1209235","volume":"334","author":"MH Smith","year":"2011","unstructured":"Smith, M. H., Ploegh, H. L. & Weissman, J. S. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 334, 1086\u20131090 (2011).","journal-title":"Science"},{"key":"96884_CR25","doi-asserted-by":"publisher","first-page":"e100875","DOI":"10.15252\/embj.2018100875","volume":"39","author":"T Toyofuku","year":"2020","unstructured":"Toyofuku, T., Okamoto, Y., Ishikawa, T., Sasawatari, S. & Kumanogoh, A. LRRK 2 regulates endoplasmic reticulum\u2013mitochondrial tethering through the PERK-mediated ubiquitination pathway. EMBO J. 39, e100875 (2020).","journal-title":"EMBO J."},{"key":"96884_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-020-0279-y","volume":"6","author":"J Obergasteiger","year":"2020","unstructured":"Obergasteiger, J. et al. Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions. Cell Death Discov 6, 45. https:\/\/doi.org\/10.1038\/s41420-020-0279-y (2020).","journal-title":"Cell Death Discov"},{"key":"96884_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","volume":"17","author":"J Mertens","year":"2015","unstructured":"Mertens, J. et al. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17, 705\u2013718 (2015).","journal-title":"Cell Stem Cell"},{"key":"96884_CR28","doi-asserted-by":"crossref","unstructured":"Li, Z.-X. & Han, J.-D. J. Neural stem cells in aging. Translat. Med. Aging (2024).","DOI":"10.1016\/j.tma.2024.12.003"},{"key":"96884_CR29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41591-019-0478-3","volume":"25","author":"B Zeitler","year":"2019","unstructured":"Zeitler, B. et al. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington\u2019s disease. Nat. Med. 25, 1131\u20131142 (2019).","journal-title":"Nat. Med."},{"key":"96884_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2015.07.002","volume":"17","author":"E Llorens-Bobadilla","year":"2015","unstructured":"Llorens-Bobadilla, E. et al. Single-cell transcriptomics reveals a population of dormant neural stem cells that become activated upon brain injury. Cell Stem Cell 17, 329\u2013340 (2015).","journal-title":"Cell Stem Cell"},{"key":"96884_CR31","doi-asserted-by":"crossref","unstructured":"Pagin, M. et al. Sox2 controls neural stem cell self-renewal through a Fos-centered gene regulatory network. bioRxiv (2020).","DOI":"10.1101\/2020.03.17.995621"},{"key":"96884_CR32","doi-asserted-by":"crossref","unstructured":"Walter, J. et al. The Parkinson\u2019s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1. Cell Rep. 37 (2021).","DOI":"10.1016\/j.celrep.2021.109864"},{"key":"96884_CR33","doi-asserted-by":"publisher","first-page":"745670","DOI":"10.3389\/fcell.2021.745670","volume":"9","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller, L., Hatzfeld, M. & Keil, R. Desmosomes as signaling hubs in the regulation of cell behavior. Front. Cell Dev. Biol. 9, 745670 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"96884_CR34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/ijms20040891","volume":"20","author":"F Santos","year":"2019","unstructured":"Santos, F., Moreira, C., N\u00f3brega-Pereira, S. & Bernardes de Jesus, B. New insights into the role of epithelial\u2013mesenchymal transition during aging. Int. J. Mol. Sci. 20, 891 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"96884_CR35","doi-asserted-by":"publisher","unstructured":"Tominaga, K. & Suzuki, H. I. TGF-beta signaling in cellular senescence and aging-related pathology. Int. J. Mol. Sci. 20, https:\/\/doi.org\/10.3390\/ijms20205002 (2019).","DOI":"10.3390\/ijms20205002"},{"key":"96884_CR36","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.biopha.2017.05.056","volume":"91","author":"C Xu","year":"2017","unstructured":"Xu, C. et al. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway. Biomed Pharmacother 91, 1167\u20131177. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.056 (2017).","journal-title":"Biomed Pharmacother"},{"key":"96884_CR37","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/hmg\/ddz181","volume":"28","author":"I Kramerova","year":"2019","unstructured":"Kramerova, I. et al. Spp1 (osteopontin) promotes TGF\u03b2 processing in fibroblasts of dystrophin-deficient muscles through matrix metalloproteinases. Hum. Mol. Genet. 28, 3431\u20133442 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"96884_CR38","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. THBS1 facilitates colorectal liver metastasis through enhancing epithelial\u2013mesenchymal transition. Clin. Translat. Oncol. 1\u201311 (2020).","DOI":"10.1007\/s12094-020-02308-8"},{"key":"96884_CR39","doi-asserted-by":"publisher","first-page":"e78935","DOI":"10.1371\/journal.pone.0078935","volume":"8","author":"C Seliger","year":"2013","unstructured":"Seliger, C. et al. Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS ONE 8, e78935. https:\/\/doi.org\/10.1371\/journal.pone.0078935 (2013).","journal-title":"PLoS ONE"},{"key":"96884_CR40","doi-asserted-by":"publisher","unstructured":"Lee, S. H. et al. Parkinson\u2019s disease subtyping using clinical features and biomarkers: Literature review and preliminary study of subtype clustering. Diagnostics (Basel) 12, https:\/\/doi.org\/10.3390\/diagnostics12010112 (2022).","DOI":"10.3390\/diagnostics12010112"},{"key":"96884_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-019-0344-2","volume":"14","author":"DC Berwick","year":"2019","unstructured":"Berwick, D. C., Heaton, G. R., Azeggagh, S. & Harvey, K. LRRK2 Biology from structure to dysfunction: Research progresses, but the themes remain the same. Mol Neurodegener 14, 49. https:\/\/doi.org\/10.1186\/s13024-019-0344-2 (2019).","journal-title":"Mol Neurodegener"},{"key":"96884_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jchemneu.2016.01.007","volume":"76","author":"SS Karuppagounder","year":"2016","unstructured":"Karuppagounder, S. S. et al. LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-mediated neurotoxicity. J. Chem. Neuroanat. 76, 90\u201397 (2016).","journal-title":"J. Chem. Neuroanat."},{"key":"96884_CR43","doi-asserted-by":"publisher","first-page":"2303711","DOI":"10.1002\/advs.202303711","volume":"10","author":"L Yao","year":"2023","unstructured":"Yao, L. et al. LRRK2 Gly2019Ser mutation promotes ER stress via interacting with THBS1\/TGF-\u03b21 in Parkinson\u2019s disease. Adv. Sci. 10, 2303711 (2023).","journal-title":"Adv. Sci."},{"key":"96884_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-021-00747-1","volume":"28","author":"JH Lee","year":"2021","unstructured":"Lee, J. H., Han, J.-H., Joe, E.-H. & Jou, I. Small heterodimer partner (SHP) aggravates ER stress in Parkinson\u2019s disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation. J. Biomed. Sci. 28, 1\u201319 (2021).","journal-title":"J. Biomed. Sci."},{"key":"96884_CR45","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/hmg\/dds003","volume":"21","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet. 21, 1931\u20131944 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"96884_CR46","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1093\/hmg\/ddx320","volume":"26","author":"EH Howlett","year":"2017","unstructured":"Howlett, E. H. et al. LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson\u2019s disease. Hum. Mol. Genet. 26, 4340\u20134351 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"96884_CR47","doi-asserted-by":"crossref","unstructured":"Singh, F. et al. Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice. elife 10, e67604 (2021).","DOI":"10.7554\/eLife.67604"},{"key":"96884_CR48","doi-asserted-by":"publisher","first-page":"691881","DOI":"10.3389\/fnagi.2021.691881","volume":"13","author":"H Ren","year":"2021","unstructured":"Ren, H., Zhai, W., Lu, X. & Wang, G. The cross-links of endoplasmic reticulum stress, autophagy, and neurodegeneration in Parkinson\u2019s disease. Front. Aging Neurosci. 13, 691881 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"96884_CR49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fnins.2020.00498","volume":"14","author":"M Madureira","year":"2020","unstructured":"Madureira, M., Connor-Robson, N. & Wade-Martins, R. LRRK2: Autophagy and lysosomal activity. Front. Neurosci. 14, 498 (2020).","journal-title":"Front. Neurosci."},{"key":"96884_CR50","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/cells8070748","volume":"8","author":"J\u00c1 Mart\u00ednez-Men\u00e1rguez","year":"2019","unstructured":"Mart\u00ednez-Men\u00e1rguez, J. \u00c1., Tom\u00e1s, M., Mart\u00ednez-Mart\u00ednez, N. & Mart\u00ednez-Alonso, E. Golgi fragmentation in neurodegenerative diseases: Is there a common cause?. Cells 8, 748 (2019).","journal-title":"Cells"},{"key":"96884_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275\u2013280 (2009).","journal-title":"Nat. Biotechnol."},{"key":"96884_CR52","doi-asserted-by":"publisher","first-page":"114124","DOI":"10.1016\/j.expneurol.2022.114124","volume":"355","author":"CM Willis","year":"2022","unstructured":"Willis, C. M. et al. Soluble factors influencing the neural stem cell niche in brain physiology, inflammation, and aging. Exp. Neurol. 355, 114124 (2022).","journal-title":"Exp. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96884-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96884-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96884-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:07:16Z","timestamp":1744286836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96884-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96884"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96884-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12286"}}